Women, thrombosis, and cancer: A gender-specific analysis

Thromb Res. 2017 Mar;151 Suppl 1:S21-S29. doi: 10.1016/S0049-3848(17)30062-2.

Abstract

Venous thromboembolism (VTE) is a major common complication in cancer patients. Risk-adapted thromboprophylaxis and antithrombotic therapy for patients diagnosed with VTE can reduce the recurrence of VTE events. Thrombotic risk varies according to cancer type, stage, and comorbidities. The current review analyzes most recent data and provides clinical guidance for the management of women with cancer-associated thrombosis.

Keywords: Anticoagulant; Contraception; Hormone therapy; Low-molecular-weight heparin; Pregnancy; Sex differences; Venous thrombosis.

Publication types

  • Review

MeSH terms

  • Anticoagulants / therapeutic use
  • Aromatase Inhibitors / therapeutic use
  • Female
  • Humans
  • Neoplasms / complications*
  • Neoplasms / epidemiology
  • Postmenopause
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / drug therapy
  • Pregnancy Complications, Cardiovascular / epidemiology
  • Pregnancy Complications, Neoplastic / epidemiology
  • Risk Factors
  • Thrombosis / drug therapy*
  • Thrombosis / epidemiology*
  • Venous Thromboembolism / drug therapy*
  • Venous Thromboembolism / epidemiology*

Substances

  • Anticoagulants
  • Aromatase Inhibitors